Controlled delivery of HIF-1α via extracellular vesicles with collagen-binding activity for enhanced wound healing
Sungmi Jeon,
No information about this author
Seongeon Cho,
No information about this author
Seongkyeong Yoo
No information about this author
et al.
Journal of Controlled Release,
Journal Year:
2025,
Volume and Issue:
380, P. 330 - 347
Published: Feb. 8, 2025
Language: Английский
Molecular Insights into Ischemia–Reperfusion Injury in Coronary Artery Disease: Mechanisms and Therapeutic Implications: A Comprehensive Review
Sai Nikhila Ghanta,
No information about this author
Lakshmi Prasanna Vaishnavi Kattamuri,
No information about this author
Adetayo Odueke
No information about this author
et al.
Antioxidants,
Journal Year:
2025,
Volume and Issue:
14(2), P. 213 - 213
Published: Feb. 13, 2025
Coronary
artery
disease
remains
a
leading
cause
of
morbidity
and
mortality
worldwide.
Acute
myocardial
infarction
results
in
ischemia-induced
cellular
dysfunction
death.
While
timely
reperfusion
limits
damage,
it
paradoxically
triggers
ischemia-reperfusion
injury
(IRI),
exacerbating
tissue
damage.
IRI,
first
observed
the
1960s,
is
mediated
by
complex
molecular
pathways,
including
oxidative
stress,
calcium
dysregulation,
endothelial
dysfunction,
inflammation.
This
review
examines
emerging
therapeutic
strategies
targeting
ischemic
preconditioning,
postconditioning,
pharmacological
agents,
anti-inflammatory
therapies.
Preconditioning
serves
as
an
endogenous
protection
mechanism,
while
postconditioning
has
become
more
clinically
feasible
approach
to
target
inflammation,
apoptosis
during
reperfusion.
Pharmacological
such
GSK-3β
inhibitors,
JNK
mesenchymal
stem
cell-derived
exosomes,
have
shown
promise
modulating
Wnt/β-catenin
NF-κB,
reduce
enhance
recovery.
Combination
therapies,
integrating
agents
with
mechanical
provide
synergistic
further
protect
mitigate
However,
translating
preclinical
findings
clinical
practice
challenging
due
discrepancies
between
animal
models
human
conditions,
particularly
comorbidities
diabetes
hypertension.
Continued
research
essential
refine
these
optimize
application,
address
translational
challenges
improve
outcomes
IRI.
Language: Английский
Frozen Shoulder as a Metabolic and Immune Disorder: Potential Roles of Leptin Resistance, JAK-STAT Dysregulation, and Fibrosis
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(5), P. 1780 - 1780
Published: March 6, 2025
Frozen
shoulder
(FS)
is
a
complex
and
multifactorial
condition
characterized
by
persistent
inflammation,
fibrosis,
metabolic
dysregulation.
Despite
extensive
research,
the
underlying
drivers
of
FS
remain
poorly
understood.
Recent
findings
indicate
coexistence
pro-inflammatory
fibrosis-resolving
macrophages
within
affected
tissues,
suggesting
dysregulated
immune
response
influenced
neuroendocrine
factors.
This
review
proposes
that
leptin
resistance,
hallmark
syndrome
chronic
may
play
central
role
in
pathogenesis
impairing
macrophage
polarization,
perpetuating
disrupting
fibrosis
resolution.
The
JAK-STAT
signaling
pathway,
critically
modulated
further
contribute
to
dysregulation
sustaining
inflammatory
activation
interfering
with
tissue
remodeling.
Additionally,
shares
pathogenic
features
fibrotic
diseases
driven
TGF-β
signaling,
mitochondrial
dysfunction,
circadian
disruption,
linking
systemic
dysfunction
localized
pathology.
Beyond
regulation,
alterations
gut
microbiota,
bacterial
translocation,
psychosocial
stress
exacerbate
inflammation
imbalances,
intensifying
resistance.
By
examining
intricate
interplay
between
metabolism,
function,
remodeling,
this
highlights
targeting
sensitivity,
modulation,
restoration
as
novel
therapeutic
strategies
for
treatment.
Future
research
should
explore
these
interconnections
develop
integrative
interventions
address
both
FS,
ultimately
improving
clinical
outcomes.
Language: Английский
Exosome-based therapies for inflammatory disorders: a review of recent advances
Stem Cell Research & Therapy,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Dec. 18, 2024
Exosomes,
small
extracellular
vesicles
secreted
by
cells,
have
emerged
as
focal
mediators
in
intercellular
communication
and
therapeutic
interventions
across
diverse
biomedical
fields.
Inflammatory
disorders,
including
inflammatory
bowel
disease,
acute
liver
injury,
lung
neuroinflammation,
myocardial
infarction,
are
complex
conditions
that
require
innovative
approaches.
This
review
summarizes
recent
advances
exosome-based
therapies
for
highlighting
their
potential
diagnostic
biomarkers
agents.
Exosomes
shown
promise
reducing
inflammation,
promoting
tissue
repair,
improving
functional
outcomes
preclinical
models
of
disorders.
However,
further
research
is
needed
to
overcome
the
challenges
associated
with
exosome
isolation,
characterization,
delivery,
well
fully
understand
mechanisms
action.
Current
limitations
future
directions
underscore
need
enhanced
isolation
techniques
deeper
mechanistic
insights
harness
exosomes'
full
clinical
applications.
Despite
these
challenges,
hold
great
treatment
disorders
may
offer
a
new
paradigm
personalized
medication.
Language: Английский
Targeting the tumor microenvironment with mesenchymal stem cells based delivery approach for efficient delivery of anticancer agents: An updated review
Yu Yang,
No information about this author
Tao Ying,
No information about this author
Jingru Ma
No information about this author
et al.
Biochemical Pharmacology,
Journal Year:
2024,
Volume and Issue:
unknown, P. 116725 - 116725
Published: Dec. 1, 2024
Language: Английский
Immunomodulatory effect of mesenchymal stem cells‐derived extracellular vesicles to modulate the regulatory T cells and Th1/Th2 imbalance in peripheral blood mononuclear cells of patients with allergic rhinitis
Scandinavian Journal of Immunology,
Journal Year:
2024,
Volume and Issue:
100(6)
Published: Oct. 29, 2024
Mesenchymal
stem
cell-derived
extracellular
vesicles
(MSC-EVs)
have
shown
promising
immunomodulatory
capabilities
for
a
variety
of
clinical
conditions.
However,
the
potential
regulatory
mechanisms
MSC-EVs
in
allergic
rhinitis
(AR)
remain
unexplored.
The
present
study
was
designed
to
investigate
effect
patients
with
AR.
Peripheral
blood
mononuclear
cells
(PBMCs)
were
isolated
from
AR
patients.
number
peripheral
CD4
Language: Английский